Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large-Cell, Anaplastic × merphos × 1 year × Clear all

Sponsor

Conditions

Burkitt Lymphoma 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Myeloid, Acute 6 Leukemia, Biphenotypic, Acute 6 Myelodysplastic Syndromes 4 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Myeloid, Accelerated Phase 3 Blast Crisis 3 Lymphoma, Mantle-Cell 2 Blastic Plasmacytoid Dendritic Cell Neoplasm 2 Urinary Bladder Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Primary Myelofibrosis 1 Osteosarcoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Mouth Neoplasms 1 Medulloblastoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Down Syndrome 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 8 Nivolumab 4 Biopsy 4 fludarabine 3 Specimen Handling 3 Prednisone 3 Magnetic Resonance Spectroscopy 3 Etoposide 3 Doxorubicin 3 Brentuximab Vedotin 3 sodium-iodide symporter 2 pembrolizumab 2 fludarabine phosphate 2 cemiplimab 2 X-Rays 2 Whole-Body Irradiation 2 Vincristine 2 Rituximab 2 Positron-Emission Tomography 2 Photons 2 Mycophenolic Acid 2 Ipilimumab 2 Immunoglobulin G 2 Filgrastim 2 Disulfides 2 Cyclosporine 2 CTLA-4 Antigen 2 10-propargyl-10-deazaaminopterin 2 treosulfan 1 talimogene laherparepvec 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡